FibroBiologics Sets $8 Reference Price for Today’s Nasdaq Direct Listing

FibroBiologics announced that trading of its stock began today in a on the Nasdaq under symbol FBLG. Thw reference price was set at $8 a share.

Houston-based FibroBiologics is a clinical-stage biotechnology company focused on the development of therapeutics and potential cures for chronic diseases using fibroblasts and fibroblast-derived materials.

The company intends to offer 4,806,226 shares in the listing.

A private placement was completed over a year ago at the equivalent of $6.76 per share, according to the prospectus.

FibroBiologics holds 150+ US and internationally issued patents/patents pending across various clinical pathways, including disc degeneration, orthopedics, multiple sclerosis, wound healing, reversing organ involution and cancer. Read more.

Source: FibroBiologics Sets Reference Price for Today's Nasdaq Direct Listing